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Abstract: The aim of our study was to assess whether cerebral artery clots undergo time-dependent
morphological and compositional changes in acute ischemic stroke. We performed a retrospective
chart review of patients admitted within 5 h from symptom onset to three European stroke centers
and evaluated non-contrast-enhanced CT (NECT) for hyperdense artery signs (HAS) in 2565 scans.
The occlusion site, density of HAS expressed in Hounsfield units (HU), area of HAS, and relative
density (rHU) (HU clot/HU non-affected artery) were studied and related to time from symptom
onset, clinical severity, stroke etiology, and laboratory parameters. A HAS was present in the middle
cerebral artery (MCA) in 185 (7.2%) and further explored. The mean time from symptom onset to CT
was 100 min (range 17–300). We found a time-dependent loss of density in the occluded M1 segment
within the first 5 h (N = 118, 95% CI [−15,−2], p = 0.01). Further, the thrombus area in the M2 segment
decreased with time (cubic trend N = 67, 95% CI [−63, −8], p = 0.02). Overall, and especially in the
M2 segment, a lower clot area was associated with higher fibrinogen (−21.7%, 95% CI [−34.8, −5.8],
p = 0.009). In conclusion, our results disclosed time-dependent changes of intracranial thrombi with
regard to occlusion site, density and area.
Keywords: acute ischemic stroke; intracranial clot; vascular disease; atherosclerosis; neuroimaging;
hyperdense artery sign; biomarker
1. Introduction
Acute occlusion of intracranial vessels is responsible for up to 80% of ischemic strokes [1,2].
The susceptibility of clot material to reperfusion therapy is being actively researched; however, more
data is needed to fill the knowledge gap [3–6]. The composition of clots is thought to be dependent
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on the embolic source. Hence, fibrin-rich “white” thrombi are presumed to originate from high-flow
larger arteries and thrombi with a predominant red blood cell (RBC) composition are more likely to
stem from low-flow cardiac sources [3]. The clots composed predominantly of RBC are considered
to be fresh, less compact and more hyperdense than fibrin-rich clots. After local plaque rupture in
coronary vessels, the development of proximal and distal of fibrin-/thrombocyte-rich nidus have been
reported [7]. A similar mechanism could take place for embolized clots in acute ischemic stroke (AIS).
Indeed, interspersed formations of fibrin-platelet-rich deposits with linear collections of nucleated
cells and erythrocytes have also been reported in AIS [4]. Several later studies, however, disclosed
that the thrombi from these two locations do not differ in composition, being heterogeneous with both
fibrin- and RBC-rich layers interspersed, probably reflecting time-dependent changes [4,8]. A recent
CT densitometry study hypothesized that the clot loses its density by acquiring fibrin, since more
hypodense clots were found in patients with lower fibrinogen values [9]. The RBC count, on the other
hand, showed no correlation with clot density. In addition, the fibrinogen serum levels were lower in
patients with larger intracranial clots.
In AIS, the hyperdense artery sign (HAS) on non-contrast-enhanced computed tomography
(NECT) is thought to represent the intraluminal thrombus and subsequent arterial obstruction. A recent
meta-analysis found a sensitivity and specificity of HAS for arterial obstruction on angiography of
52% and 95%, respectively [10]. Of note, thrombus characteristics can be evaluated reliably on
non-contrast-enhanced CT by further characterizing the HAS [11,12]. In this regard, thrombi with
lower Hounsfield units (HU) on NECT appear to be more resistant to pharmacological lysis and
mechanical thrombectomy [11,13–15]. Given the varied choice of catheters and techniques currently
available, pre-therapeutic thrombus characterization may help in the selection of the most effective
method [16]. Here, we present the results of the retrospective three-center study on the time-dependent
thrombus dynamics seen as HAS on NECT in patients with AIS.
2. Results
2.1. Patient Eligibility and Characteristics
Of the 2562 patients with NECT scans, a HAS was present in 270 cases. Of those, 250 patients
had the time between symptom onset and NECT scan exactly recorded: in 41 patients the elapsed
time was >300 min (up to 960) (Figure 1). To avoid a potential bias arising from a lower number of
patients beyond 300 min, only the patients with NECT performance within 300 min were selected for
detailed analysis. Among the remaining 209, an occlusion of the middle cerebral artery (MCA) was by
far prevailing (Figure 1).
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To avoid a further bias due to low patient numbers for other occluded vessels, the present analysis
was restricted to 185 patients with MCA involvement (Figure 1). Clinical details are depicted in Table 1
and give insight to characteristics of the entire cohort and in subgroups stratified for the affected MCA
segment (proximal or distal). Patient subsets by MCA segment were fairly comparable in all aspects,
except that thrombectomy was, by far, more frequently performed when proximal MCA was affected
(Table 1).
Table 1. Patient characteristics, overall and by the affected medial cerebral artery (MCA) segment. Data
are median (range) or count (percent), unless otherwise stated.
Variables
All Patients Proximal MCA Distal MCA
N Values N Values N Values
Age (years) 185 75 (19–98) 118 75 (41–97) 67 75 (19–98)
Men 185 82 (44.3) 118 52 (44.1) 67 30 (44.8)
Symptom onset to NECT (min) 185 100 (17–300)(Q1–Q3 = 71–136) 118
104 (31–286)
(Q1–Q3 = 71–133) 67
94 (17–300)
(Q1–Q3 = 70–147)
Side affected (left/right) 185 92 (49.7)/93 118 62 (52.5)/56 67 30 (44.8)/37
Average clot density (HU) 185 46.3 (36.1–56.1) 118 46.5 (36.9–56.1) 67 45.9 (36.1–55.3)
Non-affected side density (HU) 185 35.8 (18.6–45.7) 118 35.7 (24.4–45.7) 67 33.9 (18.6–45.7)
Ratio clot/non-affected rHU 185 1.30 (0.86–2.75) 118 1.30 (1.02–2.18) 67 1.32 (0.86–2.75)
Hyperdense area (mm2) 176 30.2 (2.5–211.4) 115 31.7 (2.9–211.4) 61 28.2 (2.5–119.0)
Admission NIHSS 185 16 (0–32) 118 17 (0–32) 67 13 (0–32)
TOAST class 185 118 67
Cardioembolic 93 (50.3) 59 (50.0) 34 (50.8)
Large artery atherosclerosis 23 (12.4) 20 (16.9) 3 (4.5)
Other (all arterial dissections) 6 (3.2) 4 (3.4) 2 (3.0)
Undetermined 9 (4.9) 3 (2.5) 6 (8.9)
Unknown 54 (29.1) 32 (27.1) 22 (32.8)
Angiography performed * 185 118 (63.8) 118 89 (75.4) 67 29 (43.3)
Thrombolysis 185 139 (75.1) 118 90 (76.3) 67 49 (73.1)
Thrombectomy 185 52 (28.1) 118 48 (40.7) 67 4 (6.0)
Thrombolysis + thrombectomy 185 44 (23.8) 118 40 (33.9) 67 4 (6.0)
Usage of antiplatelets 185 55 (29.7) 118 33 (28.0) 67 22 (32.8)
Usage of anticoagulants 185 19 (10.3) 118 12 (10.2) 67 7 (10.5)
History of stroke or TIA 185 25 (13.5) 118 14 (11.9) 67 11 (16.4)
Peripheral arterial disease 185 14 (7.6) 118 9 (7.6) 67 5 (7.5)
Atrial fibrillation 185 91 (49.5) 118 56 (47.5) 67 35 (53.0)
Diabetes mellitus 185 31 (16.8) 118 19 (16.1) 67 12 (17.9)
Arterial hypertension 185 127 (68.6) 118 84 (71.2) 67 43 (64.2)
Carotid stenosis >50% 185 24 (13.0) 118 16 (13.6) 67 8 (11.9)
Chronic heart failure 185 30 (16.2) 118 21 (17.8) 67 9 (13.4)
Blood glucose (mg/dL) 184 119 (76–351) 118 119 (76–254) 66 120 (77–351)
Total cholesterol (mg/dL) 160 181 (78–300) 102 185 (78–300) 58 175 (99–275)
Serum fibrinogen (mg/dL) 170 346 (55–785) 111 350 (166–785) 59 335 (55–685)
* Computed tomography or/and magnetic resonance or/and digital subtraction angiography. HU—Hounsfield
units; NECT—non-contrast enhanced computed tomography; NIHSS—National Institutes of Health Stroke
Scale score; TIA—transitory ischemic attack; TOAST—trial of Org 10172 in acute stroke treatment criteria.
2.2. Univariate Association between Timing of NECT (Non-Contrast-Enhanced CT) Relative to Symptom
Onset and Ratio of Density (rHU) or Hyperdense Area
Initial exploration of the relationship between the timing of NECT relative to symptom onset
(time-lag) and the ratio of the density (rHU) or hyperdense area indicated that these relationships were
apparently different at the proximal and distal MCA (Figure 2). In detail, rHU tended to decrease
with a longer time-lag at the proximal MCA but not at the distal MCA, and the difference between
the slopes of the two regression lines of ln(rHU) vs. time was significant (p = 0.019). In contrast, the
hyperdense area tended to decrease with a longer time-lag at the distal MCA, but not at the proximal
MCA. The difference between the slopes of the two regression lines of ln(hyperdense area) vs. time
was significant (p = 0.018).
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Figure 2. Exploration of the relationship between timing of NECT relative to symptom onset and ratio
of density (rHU) (left) or hyperdense area (right). A separate linear mixed model (center as a cluster)
was fitted to ln-transformed rHU and hyperdense area (to achieve normality of residuals) with time,
MCA segment and time × MCA segment interaction term as independent variables. In the analysis
of ln(rHU), there was no overall effect of time (F = 0.05, p = 0.824) and no overall difference between
the MCA segments (F = 1.21, p = 0.274), but the interaction term was significant (F = 5.61, p = 0.019).
Difference in slopes of ln(rHU) vs. time (per 60 min) at the two MCA segments is depicted numerically.
Similarly, in the analysis of ln(hyperdense area), there was no overall effect of time (F = 1.27, p = 0.261)
and no overall difference between the two MCA segments (F = 0.00, p = 0.964), but the interaction term
was significant (F = 5.68, p = 0.018). Difference in slopes of ln(hyperdense area) vs. time (per 60 min) at
the two MCA segments is depicted numerically.
Since the sample was limited, and particularly for the MCA subset groups with inadequate power
for an analysis based on an interaction term (MCA segment × time), we assessed the relationships of
interest separately at the proximal MCA and the distal MCA. Moreover, we treated time as a categorical
variable (by quartiles, see Table 1 for limit values) since cases for the later time-lag were relatively
sparse and variable. The relationship between the rHU and hyperdense area vs. quartiles of time-lag
is shown in Figure 3. The key findings were:
(a) rHU decreased linearly across quartiles of time (linear trend p = 0.025) at the proximal MCA and
values at Q4 were 9% lower than at Q1 (p = 0.010) (Figure 1A); at the distal MCA, an apparent
cubic trend (p = 0.016) was observed since rHU values declined from Q1 to Q2 and then increased
at Q3 and Q4, and hence values at Q4 were actually no different than the values at Q1 (Figure 3A);
(b) At the proximal MCA, there was no apparent difference regarding the hype dense area across
quartiles of t me (Figure 3B), whereas at distal MCA th re was a significant cubic trend
(p = 0.017)—the values slightly increased f om Q1 to Q3, and then declined at Q4, so that the
values at Q4 were 42% lower than at Q1 (p = 0.020) (Figure 3B).
2.3. Multivariate (Independent) Association between Timing of NECT Relative to Symptom Onset and Ratio of
Density (rHU) or Hyperdense Area
With adjustment for age, we analyzed the clinical s verity of disease at presentation (represented
by th NIHSS o e) and stroke etiology (TOAST criteria) categorized as “cardioembolic”, “large
artery atherosclerosis” (two readily identifiable categories with specific, distinct pathophy iology) and
“other” (unknown or undetermined) with different readouts of clot char cteristics. The relatio ship
between the timing of NECT relative to the symptom onset and rHU and hyperdense area remained
practically unchanged (Table 2). Further findings were:
(a) At the proximal MCA, the rHU linearly decreased across quartiles of the time-lag (linear trend
p = 0.019) and values at the fourth quartile were 10% lower than at the first quartile (p = 0.008); at
the distal MCA, the cubic trend remained significant and there was no difference in rHU at the
fourth vs. first quartile of the time-lag; and
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(b) At the proximal MCA there was no apparent change in the hyperdense area across quartiles of
the time-lag, whereas at the distal MCA the cubic trend remained significant and values at the
fourth quartile were 39% lower than at the first quartile (Table 2).
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Figure 3. Univariate relationship between timing of NECT relative to symptom onset (as quartiles of
time-lag) and ratio of density (rHU) (A) or hyperdense area (B) by segment of medial cerebral artery
(MCA). (A) A mixed model (center as a cluster) was fitted to ln-transformed rHU (to achieve normality
of residuals) with time-lag as the only independent variable. The relationship was tested for a linear,
quadratic and cubic trend. At the proximal MCA, a significant linear decreasing trend was observed
(depicted numerically) across quartiles of time-lag and values at the fourth quartile of elapsed time
were by 9% lower than at the first quartile. At the dist l MCA, values at the second quartile were
lower than at the first quartile of the tim -lag, and the inc eased to th third and fourth q artile,
yielding a significant cubic trend (d picted numerically); however val es at the fourth quartile of the
time-lag were closely similar to the values at the first quartile; (B) The same an lysis was repeated for
the ln-transformed hyperdense area. At the proximal MCA, no apparent trend across quartiles of time
was observed and values at the fourth quartile were closely similar to the values at the first quartile.
At the distal MCA, values slightly increased towards the third quartile and then decreased to the fourth
quartile of the time-lag, yielding a significant cubic trend (depicted numerically), and values at the
fourth quartile were 42% lower than at the first quartile. Percentage difference between the fourth and
the first quartile of time-lag = (1 − ecoeff) × 100.
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Table 2. Independent association between timing of NECT relative to the symptoms onset and ratio of
density (rHU) or hyperdense area: summary of adjusted effects.
Associations
At Proximal MCA At Distal MCA
Estimate (95% CI) p Estimate (95% CI) p
Dependent: rHU
Linear trend across time-lag quartiles −0.280 (−0.513, −0.046) 0.019 0.230 (−0.224, 0.684) 0.315
Cubic trend across time-lag quartiles −0.169 (−0.404, 0.066) 0.158 −0.480 (−0.914, −0.046) 0.031
Difference in fourth to first quartile (%) −10 (−16, −3) 0.008 2 (−11, 17) 0.761
Dependent: hyperdense area
Linear trend across time-lag quartiles 0.652 (−0.543, 1.848) 0.282 −0.976 (−2.586, 0.671) 0.243
Cubic trend across time-lag quartiles −0.906 (−2.104, 0.292) 0.137 −2.092 (−3.672, −0.512) 0.011
Difference in fourth to first quartile (%) 11 (−24, 62) 0.581 −39 (−63, −1) 0.046
A separate mixed model (center as a cluster) was fitted to the ln-transformed rHU and hyperdense area (to
achieve normality of residuals) with quartiles of time-lag, age, NIHSS score at admission and stroke etiology by
TOAST criteria (categorized as “cardioembolic”, “large artery atherosclerosis” or “other”) as independents, and
the linear, quadratic and cubic relationships between time and dependent variables were tested. Depicted are
adjusted effects. Percentage difference between the fourth and the first quartile of time-lag = (1 − ecoeff) × 100.
2.4. Exploration of the Relationship between Serum Fibrinogen Levels and rHU or Hyperdense Area
On-admission serum fibrinogen levels were available for 170/185 patients (91.9%). Among these
patients there were 111/118 (94.1%) with proximal MCA and 59/67 (88.1%) with distal MCA pathology.
A separate mixed model (center as a cluster) was fitted to ln(rHU) and ln(hyperdense area) with the
MCA segment, serum fibrinogen, stroke type (by TOAST criteria) and MCA segment × fibrinogen
interaction term. Figure 4 depicts adjusted regressions of either dependent variable on the serum
fibrinogen and adjusted estimates are shown in Table 3. In detail, we found:
(a) there was an overall trend of association between higher serum fibrinogen and higher rHU (2.3%
higher with 100 mg/dL increase in fibrinogen). However, there was no association between
fibrinogen and rHU in patients with an affected proximal MCA, whereas the association was
stronger and statistically significant in patients with an affected distal MCA (4.2% higher rHU by
100 mg/dL increase in fibrinogen);
(b) for the entire cohort, higher fibrinogen was associated with a smaller hyperdense area (15% by
100 mg/dL increase in fibrinogen) (p = 0.005). However, this association was much weaker and
not statistically significant in patients with an affected proximal MCA, whereas it was stronger
and significant in patients with an affected distal MCA (Table 3). Due to incompleteness, data
should be viewed with caution, but suggest that at proximal MCA, rHU apparently declines over
the first 300 min after the stroke onset, though the hyperdense area does not appear to change.
Further, neither of these two radiological outcomes seems to be associated with serum fibrinogen
levels. Moreover, at the distal MCA, rHU does not appear to change while the hyperdense area
tends to diminish over the first 300 min after the stroke onset. At the same time, a higher rHU
and lower hyperdense area appear to be associated with higher serum fibrinogen.
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Figure 4. Adjusted regression lines of ln-transformed rHU (left) and hyperdense area (right) vs. serum
fibrinogen, overall and by the segment of medial cerebral artery (MCA). Regressions are from the
model depicted in Table 3.
Table 3. Associ tion between se um fibrinoge and ratio of density (rHU) or hype dense area:
summary of adjusted effects expressed as % change in dependent variable by 100 mg/dL increase in
serum fibrinogen.
Affected Artery
rHU Hyperdense Area (mm2)
Estimate (95% CI) p Estimate (95% CI) p
Proximal and d l CA 2.27% (−0 0, 4.67) 0.059 −15.2% (−24.3, −5.0) .005
Proximal MCA 0.41% (−2.23, 3.17) 0.769 −8.2% (−29.3, 4.5) 0.191
Distal MCA 4.16% (0.39, 8.08) 0.031 −21.7% (−34.8, −5.8) 0.009
A separate mixed model (center as a cluster) was fitted to the ln-transformed rHU and hyperdense area (to
achieve normality of residuals) with quartiles of time-lag, stroke etiology by TOAST criteria (categorized
as “cardioembolic”, “large artery atherosclerosis” or “other”), serum fibrinogen levels, MCA segment and
fibrinogen × MCA segment interaction as independent variables. Percentage change in rHU or hyperdense
area = (1 − ecoeff) × 100.
3. Discussion
The efficacy of recanalization efforts in AIS is variable and biomarkers for stratifying patients
with a lower probability of success are eagerly awaited. The anatomical site, composition and spread
of clot in various arteries are potential parameters which could assist decision-making processes
in order to individually optimize treatment [17,18]. NECT is a fast, widely available and readily
used method in acu e stroke and it enables non-inv sive thrombus charac erization. Importantly,
thrombus characterization by NECT could provide additional useful inform tion regarding clot
susceptibility to thrombolysis and mechanical recanalization. Clot characteristics, however, could
undergo dynamic changes over time as a multitude of biochemical pathways are activated when
a vessel is occluded and the clot is exposed to hemodynamic and humoral changes of the local
milieu [19–21]. These include a combination of proximal and distal apposition of new thrombotic
material as well as proteolytic processes, which dissolve less compact thrombus material and leave a
place for further fibrin meshwork propagation.
Here, we found indirect evidence of changes i clot composition and morph logy within the
first 5 h of AIS. Our study disclosed that CA M1 clots, but not MCA M2 loses its de sity within
the first 5 h. Moreover, we report a declin of the clot plan over time for the M2 segment. The area
reduction was also associated with higher fibrinogen blood levels, which corroborates our previous
observation [9]. The clots situated in the M1 segment did not change with regard to area and time, and
thrombus characteristics did not correlate with fibrinogen levels.
Why is there a difference between the proximal and distal MCA occlusion with regard to
time-dependent changes? This observation could, on one hand, be related to differences of embolic
material, and indeed, large artery atherosclerosis was a more frequent etiology in M1 segment occlusion
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(16.9% vs. 4.5%). The other factor playing a possible role could be the availability of collateral perfusion
regarding the occluded segment. This issue was not assessed in our study. Although there are
conflicting reports, Kim et al. found higher proportions of RBCs and a lower proportion of fibrin in
clots arising from cardioembolic (CE) than in those with large artery arteriosclerosis (LAA) etiology.
The predominant histology of distal clots is not reported in published studies. Accordingly, we could
speculate that distal thrombi, having originally more fibrin content that is more resistant to endogenous
lysis, shield the RBC-rich part from degradation and accordingly these clots do not change in density
with time. However, the later the patient arrives, the area of the distal thrombi seems to be somewhat
smaller, possibly reflecting the degradation of RBC content later in time since the change is not obvious
until the last quartile of time.
A time-dependent drop in clot density (absolute HU) was previously reported by Topcuoglu et al. [22].
In contrast to our findings, one study with 106 patients showed no changes in the relative HU density
of the hyperdense artery within the first 4.5 h [23]. The reason for this discrepancy remains unclear.
The density of the clot as seen on NECT is augmented by RBC content. Loss of density after embolism
in MCA M1 occlusion is probably due to the preferential degradation of the erythrocyte-rich part of
the clot [7]. Reports from a murine ischemic model provide evidence that the urokinase plasminogen
activator is activated in the first 1 to 2 h following acute MCA occlusion, with gradual weakening of
activity thereafter, which could explain our observation [19].
The second largest group concerning stroke pathogenesis consisted of patients with unknown
etiology, accounting for 29%. Although we have not specifically reassessed details of the
diagnostic stroke workup, the usual standard of care in stroke units includes blood analysis, 24 h
electrocardiography (ECG), heart ultrasound and vessel imaging in every patient. Accordingly, it is
unlikely that a lack of workup is responsible for this unexpectedly high number of cryptogenic strokes.
With the presence of the intracranial clot, many of these patients could be classified as embolic stroke
of undetermined source (ESUS) as the underlying etiology [24]. The prevalence of cryptogenic or
ESUS strokes in cohorts with evaluation of the HAS is rarely reported. A pilot study identified nine
patients with HAS of the MCA, which accounted for 20% of all stroke cases. Cryptogenic and ESUS
stroke made up 26% of stroke cases in a larger study [25]. One study revealed that patients without
detectable stroke etiology may have better clinical outcomes [26]. Further studies are required to prove
whether hints for stroke etiology could be determined by analysis of clot morphology on NECT in
cases where the causality remains unclear from ancillary investigations.
Limitations of our study are the usage of different scanning parameters and non-uniform slice
thickness. This influences the detection rate of HA which is known to be dependent on slice thickness,
and studies confirmed that thinner NECT slices have a greater sensitivity [12]. In addition, the rather
low detection rate of HA in nearly 10% of all consecutive strokes could be interpreted as low sensitivity
of our study. However, the prevalence of the HA sign among non-selected stroke patients and larger
cohorts has not been reported so far. Selected populations, i.e., patients chosen for thrombolysis or with
specific stroke syndromes such as posterior cerebral artery stroke, have higher detection rates, but this
varies widely (5%–75%) [27]. In our study, some form of angiography (CT, magnetic resonance imaging
(MRI) or digital subtraction angiography (DSA)) was performed in 63.8% patients with a correlation of
vessel occlusion. For other patients, the clinical stroke syndrome was taken for the verification of vessel
obstruction and this always corresponded to the side of the artery occlusion. Of note, we acknowledge
the difficulty of discerning the hyperdense artery on plain CT without additional angiography but
we presume that the combination of hematocrit correction and correlation with the clinical syndrome
suffices for the identification of the occluded artery. Naturally, the presumption that time-dependent
changes can be approximated from various patients is subjected to biases. Ideally, each patient should
be re-examined with NECT at fixed time points. Such an approach, however, is not feasible due
to ethical constraints and patient safety. Nevertheless, in our population, on follow up CT scans in
45 patients, HA was still visible (29%); of them 32 (71%) showed no change or had a drop in rHU
values, thus further confirming our findings. Eventually, our observation needs to be confirmed in a
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larger cohort. Moreover, the characterization of thrombus dynamics beyond 5 h from symptom onset
should follow as well.
4. Materials and Methods
We performed a retrospective study of consecutive patients with AIS who presented to the
emergency department in three stroke centers. These were Christian-Doppler-Klinik Salzburg, Austria
(CDK), University Clinical Center Maribor, Slovenia (MB) and Bezirkskrankenhaus Lienz, Austria
(LZ). The study periods for CDK and MB were 2013–2015, and for LZ 2011–2014.
The inclusion criteria were age≥18 years, presentation within 16 h from stroke onset and available
head NECT. We excluded those cases were brain hemorrhage, brain tumor or non-stroke pathology
was seen. In addition to usual laboratory examinations we recorded HbA1c and acute fibrinogen
values. Stroke subtypes were classified according to the modified Trial of Org 10172 in Acute Treatment
(TOAST) criteria [28]. NECT was performed before treatment with rt-PA in all patients.
CT scans were acquired in LZ and CDK with the multidetector CT scanner Sensation 64 (Siemens,
Erlangen, Germany) and in MB with the multidetector CT scanner (Aquilion 64, Toshiba Medical
Systems, Tochigi, Japan). The CT scans were reconstructed into 4, 2.4 and 3 mm (for CDK, LZ and MB,
respectively) thick adjacent slices through the whole brain with the specifications of 120 kV (all centers)
and 250, 440 and 150–350 mAs (for CDK, LZ and MB respectively) (mean value, using automatic
exposure control) and matrix size of 512 × 512. The mean equivalent dose was 1.2 mSv for CDK and
LZ and 1.9 mSv for MB.
The evaluation of CT-scans were performed by two experienced stroke physicians who were
blinded to the clinical data. When in doubt of presence of hyperdense vessel sign, consensus was
reached. HAS was recognized as the area of hyperattenuating artery on NECT. The hyperdense area
was manually delineated in IMPAX software (Impax Laboratories Inc., Hayward, CA, USA), the vessel
location and the side (when applicable) were recorded. Areas with calcifications (HU > 90) were not
delineated. Measurements of hyperdense artery were made as previously described [11]. In short, the
region of interest (ROI) was manually placed on the margins of the clot. Average HU was then obtained
from all voxels within the ROI, summed across all slices (if present on more than one) producing HU
sum. The final HU value was calculated by dividing the HU sum with number of slices. We recorded
area in mm2 of manually circumscribed hyperdensity. The area was summed across slices (when
present in more than one). Analyses depending on variables including time, disease severity and
location of the HAS were performed with respective cohorts.
In order to correct for the impact of hematocrit values we measured the density of the vessel
contralateral to affected one, in the case of basilar artery hyperdensity the measurement was in posterior
cerebral artery. From measured final HU value, relative HU ratio (rHU) (final HU value divided by
average HU of contralateral/appropriate non-affected artery) was derived. After hyperdense artery
detection, the medical records were checked to ensure correspondence with clinical symptoms.
Data Analysis
In line with the study objective, data analysis was conceived to explore the relationship, univariate
and independent (adjusted), between time (defined as time elapsed between symptom onset and
NECT scan, i.e., time-lag) and the two radiological outcomes—rHU and size of the hyperdense area.
For all analyses, center was treated as a random effect to account for potential correlation of data
coming from one site. In randomized trials, this approach was shown to improve power and maintain
nominal coverage rates [29]. Univariate models contained “time” as the only fixed effect. Selection of
covariates (additional fixed effects) in multivariate models was based on rationale that adjustments
should account for biologically plausible potential confounders and/or moderators. We did not intend
to detect “all possible effects” or to define the best set of explanatory variables of variability of rHU or
hyperdense area. Finally, in an attempt to explore a potential biological background for the observed
time effects on rHU and hyperdense area, we investigated the relationship between these outcomes
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and serum fibrinogen levels at admission. All mixed models were fitted using SAS for Windows 9.4
software (SAS Inc., Cary, NC, USA).
5. Conclusions
There are time-dependent changes in MCA thrombus morphology and composition within the
first 5 h from symptom onset in patients with AIS. Moreover, we found that proximal and distal MCA
clots differ with regard to these dynamics. Further studies, ideally with the evaluation of mechanically
retrieved intracranial clots, are required to understand the complex pathophysiological processes
determining the intrinsic and extrinsic post-processing of an intracranial thrombus.
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Abbreviations
AIS Acute ischemic stroke
LAA Large artery atherosclerosis
HAS Hyperdense artery sign
NECT Non-enhanced CT
TOAST Trial of Org 10172 in Acute Treatment criteria
HU Hounsfield units
rHU Average HU of hyperdense artery/average HU of non-affected artery
DSA Digital subtraction angiography
MRI Magnetic resonance imaging
CT Computertomography
ESUS Embolic stroke of unknown source
CE Cardioembolic
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